Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000886744-17-000012
Filing Date
2017-02-10
Accepted
2017-02-10 20:15:52
Documents
1
Period of Report
2017-02-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3911
  Complete submission text file 0000886744-17-000012.txt   5388
Mailing Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE SUITE 2070 MENLO PARK CA 94025 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
SCARLETT JOHN A (Reporting) CIK: 0001270928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 17595395